Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Advances in the Management of Anal Cancer
Diana R. Julie
,
Karyn A. Goodman
Research output
:
Contribution to journal
›
Review article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in the Management of Anal Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mitomycin C
100%
Anal Cancer
100%
Radiation Therapy
66%
Anal Squamous Cell Carcinoma
66%
External Beam Radiotherapy
33%
Malignancy
33%
Chemotherapy
33%
Standard of Care
33%
Intensity-modulated Radiation Therapy
33%
Radiation Dose
33%
Papillomavirus Infections
33%
Capecitabine
33%
5-fluorouracil (5-FU)
33%
Cisplatin-based Chemotherapy
33%
Chemotherapy Agents
33%
Targeted Chemotherapy
33%
Medicine and Dentistry
Anal Cancer
100%
Mitomycin
100%
Squamous Cell Carcinoma
66%
Radiation Therapy
66%
External Beam Radiotherapy
33%
Cancer
33%
Infusion
33%
Virus Infection
33%
Wart Virus
33%
Intensity Modulated Radiation Therapy
33%
Chemotherapy Agent
33%
Cisplatin
33%
Fluorouracil
33%
Capecitabine
33%
Oral
33%